Parviz Gharagozloo from Blue Spruce Dr, Pennington, NJ 08534, age 64, Phone: (609)8189055

view source

Location:

16 Blue Spruce Dr, Pennington, NJ 08534

Industry:

Pharmaceuticals

Skills:

Cancer

Therapeutic Agents Useful For Treating Pain
view source
US Patent:

6864261, Mar 8, 2005
Filed:

May 2, 2003
Appl. No.:

10/429078
Inventors:

Parviz Gharagozloo - Pennington NJ, US
Khondaker Islam - Langhorne PA, US
Donald J. Kyle - Newtown PA, US
Qun Sun - Princeton NJ, US
Laykea Tafesse - Robinsville NJ, US
John William Frank Whitehead - Newtown PA, US
Ji Yang - Princeton Junction NJ, US
Xiaoming Zhou - Plainsboro NJ, US
Assignee:

Euro-Celtique S.A.
International Classification:

A61K031/496
C07D401/04
US Classification:

51425301, 544360, 544364
Abstract:

A compound of formula (wherein A, R, R, R, m and n are disclosed herein) or a pharmaceutically acceptable salt thereof (a “Piperazine Compound”); pharmaceutical compositions comprising a Piperazine Compound; and methods for treating pain, urinary incontinence (UI), an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis (ALS), dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia and depression in an animal comprising administering to an animal in need thereof an effective amount of a Piperazine Compound are disclosed.

Aryl Substituted Thiazolidinones And The Use Thereof
view source
US Patent:

7169782, Jan 30, 2007
Filed:

Jul 16, 2002
Appl. No.:

10/195530
Inventors:

Qun Sun - Princeton NJ, US
Donald J. Kyle - Newtown PA, US
Parviz Gharagozloo - Pennington NJ, US
Ji Yang - Princeton Junction NJ, US
Assignee:

Euro-Celtique S.A. - Luxembourg
International Classification:

C07D 277/14
C07D 417/06
A61K 31/426
A61K 31/4439
US Classification:

5142368, 514326, 514342, 514369, 544133, 546209, 5462697, 548186
Abstract:

This invention relates aryl substituted thiazolidinones of Formula I:.

Nociceptin Analogs
view source
US Patent:

7563809, Jul 21, 2009
Filed:

Mar 1, 2005
Appl. No.:

11/069728
Inventors:

R. Richard Goehring - Pipersville PA, US
Zhengming Chen - Belle Mead NJ, US
John Whitehead - Newtown PA, US
Parviz Gharagozloo - Pennington NJ, US
Sam Victory - Newtown PA, US
Donald Kyle - Newtown PA, US
Assignee:

Purdue Pharma, L.P. - Stamford CT
International Classification:

C07D 417/04
C07D 417/14
A61K 31/5415
A61P 29/00
US Classification:

514322, 546199
Abstract:

The invention relates to benzothiadiazole compounds of formula (I):and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein R, R, A, B, C, W, Z and n are defined as set forth in the specification. The compounds of the invention have affinity for the nociceptin receptor. The invention is also directed to the use of compounds of Formula (I) to treat a disorder responsive to modulation of the nociceptin receptor. Compounds of the present invention are especially useful for treating pain.

Treating Male Infertility Secondary To Sperm Oxidative Stress
view source
US Patent:

8377454, Feb 19, 2013
Filed:

Apr 30, 2010
Appl. No.:

12/771928
Inventors:

Parviz Gharagozloo - Pennington NJ, US
International Classification:

A61K 9/00
US Classification:

424400, 424451, 424464, 424641, 424702
Abstract:

A profertility composition for administration to infertile men with sperm oxidative stress is disclosed. The composition comprises a unique combination of a pharmaceutically acceptable vitamin E, vitamin C, selenium, zinc, folic acid, lycopene and at least one carnitine source.

Nociceptin Analogs
view source
US Patent:

20030013874, Jan 16, 2003
Filed:

Apr 18, 2002
Appl. No.:

10/126507
Inventors:

R. Goehring - Pipersville PA, US
Zhengming Chen - Belle Mead NJ, US
John Whitehead - Newtown PA, US
Parviz Gharagozloo - Pennington NJ, US
Sam Victory - Newtown PA, US
Donald Kyle - Newton PA, US
International Classification:

A61K031/554
C07D285/34
A61K031/549
US Classification:

540/545000, 544/010000, 514/211080, 514/222800
Abstract:

A compound of the having the general formula (I) or general formula (II): wherein Z, A, B, C, R, R, Q, W, and n are as described herein.

Nociceptin Analogs
view source
US Patent:

20090253727, Oct 8, 2009
Filed:

Jun 16, 2009
Appl. No.:

12/485612
Inventors:

R. Richard Goehring - Pipersville PA, US
Zhengming Chen - Belle Mead NJ, US
John Whitehead - Newtown PA, US
Parviz Gharagozloo - Pennington NJ, US
Sam Victory - Newtown PA, US
Donald Kyle - Newtown PA, US
Assignee:

Purdue Pharma L.P. - Stamford CT
International Classification:

C07D 401/04
A61K 31/4545
A61P 29/00
US Classification:

514278, 546158, 546 15, 514312
Abstract:

A compound of the having the general formula (I) or general formula (II):wherein

Treating Male Infertility Secondary To Sperm Oxidative Stress
view source
US Patent:

20130136802, May 30, 2013
Filed:

Jan 24, 2013
Appl. No.:

13/749177
Inventors:

Parviz Gharagozloo - Pennington NJ, US
International Classification:

A61K 33/30
A61K 31/375
A61K 31/221
A61K 31/519
A61K 31/01
A61K 31/355
A61K 33/04
US Classification:

424638, 424643
Abstract:

A profertility composition for administration to infertile men with sperm oxidative stress is disclosed. The composition comprises a unique combination of a pharmaceutically acceptable vitamin E, vitamin C, selenium, zinc, folic acid, lycopene and at least one carnitine source.

Treating Male Infertility Secondary To Sperm Oxidative Stress
view source
US Patent:

20180296597, Oct 18, 2018
Filed:

Apr 16, 2018
Appl. No.:

15/953939
Inventors:

Parviz Gharagozloo - Pennington NJ, US
International Classification:

A61K 33/30
A61K 31/519
A61K 31/221
A61K 31/355
A61K 31/375
A61K 31/385
A61K 33/04
A61K 33/06
A61K 31/01
A61K 45/06
Abstract:

A profertility composition for administration to infertile men with sperm oxidative stress is disclosed. The composition comprises a unique combination of a pharmaceutically acceptable vitamin E, vitamin C, selenium, zinc, folic acid, lycopene and at least one carnitine source.